Drug-coated balloons for patients with increased risk of bleeding

Affiliations

Comment

Bruno Scheller. Lancet. 2019.

. 2019 Jul 20;394(10194):190-192.

doi: 10.1016/S0140-6736(19)31144-4. Epub 2019 Jun 13.

¹ Clinical and Experimental Interventional Cardiology, University of Saarland, 66421 Homburg, Germany. Electronic address: bruno.scheller@uks.eu.

No abstract available

Comment on

Drug-coated balloon for treatment of de-novo coronary artery lesions in patients with high bleeding risk (DEBUT): a single-blind, randomised, non-inferiority trial.
Rissanen TT, Uskela S, Eränen J, Mäntylä P, Olli A, Romppanen H, Siljander A, Pietilä M, Minkkinen MJ, Tervo J, Kärkkäinen JM; DEBUT trial investigators. Rissanen TT, et al. Lancet. 2019 Jul 20;394(10194):230-239. doi: 10.1016/S0140-6736(19)31126-2. Epub 2019 Jun 13. Lancet. 2019. PMID: 31204115 Clinical Trial.